0HB0 fundamentals
An in-depth look to AGIOS PHARMACEUTICALS INC COM USD0.001 operating, investing, and financing activities
0HB0 free cash flow for Q3 24 is -84.64 M USD. For 2023, 0HB0 free cash flow was -297.06 M USD and operating cash flow was -296.06 M USD.
Q1 '23
Q2 '23
Q3 '23
Q4 '23
Q1 '24
Q2 '24
Q3 '24
0.00
Cash from operating activities
Cash from investing activities
Cash from financing activities
Currency: USD
Q1 '23
Q2 '23
Q3 '23
Q4 '23
Q1 '24
Q2 '24
Q3 '24
TTM